Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
427
datasets available to search
ShareScore release 0.9.0
Dataset results
427 results for “Herpes”
Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus a
ClinicalTrials.gov study NCT02052596. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India
ClinicalTrials.gov study NCT05219253. IPD Sharing: YES. Countries: 1. Publications: 2.
Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years
ClinicalTrials.gov study NCT01777321. IPD Sharing: YES. Countries: 1. Publications: 2.
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant
ClinicalTrials.gov study NCT02058589. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older
ClinicalTrials.gov study NCT02045836. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
ClinicalTrials.gov study NCT01798056. IPD Sharing: YES. Countries: 6. Publications: 2.
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older
ClinicalTrials.gov study NCT03439657. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older
ClinicalTrials.gov study NCT01165229. IPD Sharing: YES. Countries: 18. Publications: 11.
Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis
ClinicalTrials.gov study NCT02382588. IPD Sharing: YES. Countries: 1. Publications: 5.
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
ClinicalTrials.gov study NCT00098059. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
ClinicalTrials.gov study NCT01772160. IPD Sharing: YES. Countries: 1. Publications: 2.
Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older
ClinicalTrials.gov study NCT01751165. IPD Sharing: YES. Countries: 2. Publications: 1.
Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia
ClinicalTrials.gov study NCT06882525. IPD Sharing: NO. Countries: 1. Publications: 1.
Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age
ClinicalTrials.gov study NCT02075515. IPD Sharing: YES. Countries: 3. Publications: 1.
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
ClinicalTrials.gov study NCT00809809. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
ClinicalTrials.gov study NCT06903078. IPD Sharing: YES. Countries: 1. Publications: 6.
Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
ClinicalTrials.gov study NCT00920218. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
ClinicalTrials.gov study NCT01448616. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
ClinicalTrials.gov study NCT00448227. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138
ClinicalTrials.gov study NCT01954251. IPD Sharing: YES. Countries: 3. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.